Pts w/ pre-existing rheumatic conditions 3.6 times likelier to new rheumatic disease features or worsening disease after starting ICI for melanoma, Abs 0756 #ACR22 @RheumNow https://t.co/s1f1QxmJzA https://t.co/6cKllBzqJn
Links:
Rheumatic Toxicities of Immune Checkpoint Inhibitors in Patients with Advanced …
http://ow.ly/von750LxrhA
13-11-2022
